OUR RESOURCES

9th Annual Year End Review In Lung Cancer 2025

DAY 2 HALL B

Welcoming delegates & dignitaries and Comparing the workshop

Past work, Hits & Misses, Going Forward

Navigating the patients and systems in cancer care

Ground realities, obstacles and milestones in cancer screening

How to build an ecosystem for increased accessibility in cancer care

PANEL DISCUSSION: Increasing the Accessibility - Treatment, Clinical Trials, Palliative care, Rehabilitation Dr

PANEL DISCUSSION: Prevention, Screening, Policy Expectations and Possible Solutions

Global scenario of clinical trials, outcomes and accessibility in Lung Cancer

Comparison of 10-year Survival Outcomes between CT Surveillance and Surgery for Ground-Glass Nodules

Different faces of Lung Cancer-Radiologic-Pathologic Correlation

Prognostic Variability in Non–Small Cell Lung Cancer with Pathologic Separate Nodules in the Same Lobe at CT

Incorporating Lymph Node Size at CT as an N1 Descriptor in Clinical N Staging for Lung Cancer

Lung cancer-Interventions Workup: Evidence-based Approach to Transthoracic Needle Biopsy: Procedural Techniques, Risks, and Controversies

Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial

Lung Cryoablation: Patient Selection, Techniques, and Postablation Imaging

Impact of Hemoptysis Etiology and Embolic Agent Type on Prognosis in Patients Undergoing Bronchial Artery Embolization

Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients

Introduction to Pulmonary Oncology Session

Symposium 1: EBUS TBNA & Biopsies: Case 1

Case 2

Current Role of EBUS TBNA in Pulmonary & Extra Pulmonary Malignancy

Panel Discussion: Biopsies for Lung Cancer – Solid & Liquid: Why, When, What

Palliative Pulmonary Interventions in Thoracic Malignancy

Current approach to neo adjuvant therapies for adenocarcinoma lung

Current approach to adjuvant therapies for adenocarcinoma lung

Case 3

Case 4

Case 5

Management of Fungal Lung Infections in Malignancy

nel Discussion:Lung Infections in Malignancy